Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Ultragenyx's UX111 gene therapy faces FDA delay due to facility issues; analysts adjust price targets amid uncertain ...

Glycogen storage diseases (GSDs) comprise a heterogeneous group of inherited metabolic disorders that impede the normal synthesis or degradation of glycogen, resulting in diverse clinical phenotypes.

Glycogen storage diseases (GSDs) constitute a group of inherited metabolic disorders that impair normal glycogen synthesis or degradation, resulting in the accumulation of structurally abnormal ...

Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

McArdle’s disease, also known as Glycogen Storage Disease Type V, or GSD5, is a congenital disorder of muscle metabolism. This article discusses the disease in more detail.

Liver glycogen storage disease type IX (GSD IX) accounts for 25% for all GSD cases, with a prevalence of 1 out of 100,000 patients. GSD IX is caused by deficiency in phosphorylase kinase (PhK), which ...

A new study from scientists at the Buck Institute for Research on Aging has revealed a surprising player in the battle ...